NICE is considering whether the medicines recommended for treating COVID-19 in TA878, TA1056 and TA971 remain a clinically and cost-effective use of NHS resources. The review proposal has been sent to stakeholders, who have 28 days to comment on the review proposal.
You can now comment on this review proposal.
How to comment
You should read the review proposal before making any comments.
You must make your comments directly onto the online version of the review proposal. When you go into the document you will find instructions on how to use the commenting software. You can also review and edit your comments before you submit them.
You can download a PDF version of the review proposal, but you can only make comments on the online version.
Review proposal paper
Closing date for comments: 5pm, Thursday 24 September 2026.